Skip to content

Burning Rock Biotech Limited

BNR

CIK 0001792267

← back to feed
Revenue (TTM)
¥77.16M
+9.2% YoY FY Dec 2025
Net Income (TTM)
−¥55.35M
+84.0% YoY FY Dec 2025
EPS Diluted (TTM)
—
FY Dec 2025
Gross Margin
74.7%
FY Dec 2025
Operating Margin
-10.2%
FY Dec 2025
Net Margin
-71.7%
FY Dec 2025
Free Cash Flow (TTM)
−¥4.82M
FY Dec 2025
Cash
¥68.41M
FY Dec 2025
Total Debt
¥0
FY Dec 2025
Shares Outstanding
0 sh
FY Dec 2025

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings